MIRA Pharmaceuticals Inc. (MIRA)
MIRA Pharmaceuticals Statistics
Share Statistics
MIRA Pharmaceuticals has 16.81M shares outstanding. The number of shares has increased by 12.04% in one year.
| Shares Outstanding | 16.81M |
| Shares Change (YoY) | 12.04% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 12.48M |
| Failed to Deliver (FTD) Shares | 12.86K |
| FTD / Avg. Volume | 5.01% |
Short Selling Information
The latest short interest is 705.72K, so 4.2% of the outstanding shares have been sold short.
| Short Interest | 705.72K |
| Short % of Shares Out | 4.2% |
| Short % of Float | 5.66% |
| Short Ratio (days to cover) | 3.86 |
Valuation Ratios
The PE ratio is -2.24 and the forward PE ratio is -1.65. MIRA Pharmaceuticals's PEG ratio is 0.1.
| PE Ratio | -2.24 |
| Forward PE | -1.65 |
| PS Ratio | 0 |
| Forward PS | 0.4 |
| PB Ratio | 8 |
| P/FCF Ratio | -3.17 |
| PEG Ratio | 0.1 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for MIRA Pharmaceuticals.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.99, with a Debt / Equity ratio of 0.
| Current Ratio | 3.99 |
| Quick Ratio | 3.99 |
| Debt / Equity | 0 |
| Debt / EBITDA | - |
| Debt / FCF | 0 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-3.93M |
| Employee Count | 2 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by 12.66% in the last 52 weeks. The beta is 2.07, so MIRA Pharmaceuticals's price volatility has been higher than the market average.
| Beta | 2.07 |
| 52-Week Price Change | 12.66% |
| 50-Day Moving Average | 1.05 |
| 200-Day Moving Average | 1.32 |
| Relative Strength Index (RSI) | 41.27 |
| Average Volume (20 Days) | 256.84K |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | 0 |
| Net Income | -7.85M |
| EBITDA | 0 |
| EBIT | n/a |
| Earnings Per Share (EPS) | -0.51 |
Balance Sheet
The company has 2.83M in cash and 0 in debt, giving a net cash position of 2.83M.
| Cash & Cash Equivalents | 2.83M |
| Total Debt | 0 |
| Net Cash | 2.83M |
| Retained Earnings | -29.14M |
| Total Assets | 2.92M |
| Working Capital | 2.16M |
Cash Flow
In the last 12 months, operating cash flow was -5.56M and capital expenditures 0, giving a free cash flow of -5.56M.
| Operating Cash Flow | -5.56M |
| Capital Expenditures | 0 |
| Free Cash Flow | -5.56M |
| FCF Per Share | -0.36 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MIRA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for MIRA is $14, which is 1473% higher than the current price. The consensus rating is "Buy".
| Price Target | $14 |
| Price Target Difference | 1473% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
Scores
| Altman Z-Score | -10.2 |
| Piotroski F-Score | 1 |